 | Up a level |
Journal Article
Dziadziuszko, Rafal 
ORCID: 0000-0001-8080-9843, Smit, Egbert F., Dafni, Urania, Wolf, Juergen, Wasag, Bartosz ORCID: 0000-0002-3634-7562, Biernat, Wojciech, Finn, Stephen P., Kammler, Roswitha, Tsourti, Zoi, Rabaglio, Manuela, Ruepp, Barbara, Roschitzki-Voser, Heidi, Stahel, Rolf A., Felip, Enriqueta and Peters, Solange
(2019).
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP).
J. Thorac. Oncol., 14 (6).
S. 1086 - 1095.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Felip, Enriqueta, Smit, Egbert F., Molina-Vila, Miguel A., Dafni, Urania, Massuti, Bartomeu, Berghmans, Thierry, de Marinis, Filippo, Passiglia, Francesco, Dingemans, Anne-Marie C., Cobo, Manuel, Viteri, Santiago ORCID: 0000-0002-7572-1123, Britschgi, Christian ORCID: 0000-0001-8831-1564, Cuffe, Sinead, Provencio, Mariano ORCID: 0000-0001-9053-9197, Merkelbach-Bruse, Sabine, Andriakopoulou, Charitini, Kammler, Roswitha, Ruepp, Barbara, Roschitzki-Voser, Heidi, Peters, Solange, Wolf, Juergen and Stahel, Rolf
(2022).
Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.
Lung Cancer, 172.
S. 94 - 100.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1872-8332